New imaging modalities are taking away much of the work formerly done by cardiac and vascular x-ray-based procedures, and today's customers may reconsider or postpone investment decisions in the newer, more expensive cardiac and vascular x-ray technologies, according to an analysis from Frost & Sullivan of San Jose, CA.
CT and MRI are making inroads into vascular imaging using contrast agents. The market for vascular imaging is still healthy, though, producing revenue of $775.4 million in 2003, and a predicted $1 billion in 2010.
Some observers believe that cardiac x-ray will still be used to verify the results of CR and MR diagnostic exams, and that cardiovascular CT or MR will simply redistribute the x-ray procedure volume from a diagnostic case load to an interventional one, according to the report.
Frost & Sullivan's report is part of its U.S. Cardiac and Vascular X-ray Equipment Markets.
By AuntMinnie.com staff writers
November 16, 2004
Copyright © 2004 AuntMinnie.com